1 / 8

Neurodegenerative Diseases Market to 2018 - New product entr

Bharat Book Presents"Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff" analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD).

bharatbookseo
Télécharger la présentation

Neurodegenerative Diseases Market to 2018 - New product entr

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Neurodegenerative Diseases Market to 2018 Bharat Book Bureau

  2. Summary “Neurodegenerative Diseases Market to 2018 - New product entries in both niche and broader Parkinson’s disease treatment will boost market despite patent cliff”. A highly dynamic market scenario is expected in Neurodegenerative diseases in the next few years, with a number of patent expiries and anticipated new drug approvals. The market for Alzheimer’s disease has not seen any recent major breakthroughs, and is expected to experience a decline due to the patent expiry of several major products. The market for Parkinson’s disease, on the other hand, is expected to experience growth due to the anticipated approval of expensive products such as Duodopa in the US, in spite of the fact that it will soon hit its own patent cliff. Additionally, the overall aging of populations the developed world is expected to increase the number of patients suffering from these diseases due to their relatively high prevalence in the elderly.

  3. Continue… Scope- The report analyzes treatment usage patterns, market characterization, pipeline analysis, and key M&A and licensing deal trends in Alzheimer’s Disease (AD), Parkinson’s Disease (PD), Amyotrophic Lateral Sclerosis (ALS) and Huntington’s Disease (HD). - The current therapeutic environment in the treatment of AD, PD, HD and ALS across the top seven developed markets, including the US, Germany, France, the UK, Italy, Spain and Japan. - Market data on the geographical landscape and therapeutic landscape, including market size, annual cost of therapy, treatment usage patterns such as disease population and prescription populations.

  4. Continue… - Market forecasts for all four indications across the US, the top five countries in Europe (EU5) - Germany, France, the UK, Italy, and Spain- as well as Japan.- Key market drivers and barriers- The major deals that have taken place in the Neurodegenerative Diseases Market in recent years. Coverage includes Mergers and Acquisitions (M&As) as well as co-development and licensing agreements, which are segmented on the basis of geography and total value. A concomitant analysis of the licensing deal values for products by molecule types and is also provided.

  5. Continue… Reasons to buyThe report will assist business development and marketing executives to strategize their product launches, by allowing them to - - Understand the competitive environment for Neurodegenerative Diseases- Understand the clinical and commercial impact of major patent expiries in the neurodegenerative diseases markets- Assess the potential clinical and commercial impact of current late-stage pipeline molecules on the neurodegenerative diseases market in the forecast period- Grasp the unmet need which exists in the neurodegenerative diseases Market- Exploit in-licensing and out-licensing opportunities by identifying products that might fill their portfolio gaps

  6. Table of Contents 1 Table of Contents 61.1 List of Tables 91.2 List of Figures 112 Neurodegenerative Diseases Market to 2018: Introduction 133 Neurodegenerative Diseases Market to 2018: Global Market Overview 143.1 Revenue 143.2 Treatment Usage Pattern 163.3 Distribution by Market 173.4 Drivers and Restraints of the Neurodegenerative Diseases Market 183.4.1 Drivers 183.4.2 Restraints 184 Therapeutic Landscape 194.1 Market for Alzheimer’s Disease 194.1.1 Introduction 194.1.2 Revenue and Forecasts 21

  7. Continue… 4.1.3 Treatment Usage Pattern 234.1.4 Geographical Landscape 244.1.5 Drivers and Restraints for the Alzheimer’s Disease Market 464.2 Market for Parkinson’s Disease 474.2.1 Introduction 474.2.2 Revenue and Forecasts 494.2.3 Treatment Usage Pattern 504.2.4 Geographical Landscape 514.2.5 Drivers and Restraints for the Parkinson’s Disease Market 734.3 Market for Amyotrophic Lateral Sclerosis 744.3.1 Introduction 744.3.2 Revenue and Forecasts 764.3.3 Treatment Usage Pattern 774.3.4 Geographical Landscape 784.3.5 Drivers and Restraints for the Amyotrophic Lateral Sclerosis Market 100

  8. For More Information You Can Visit- http://www.bharatbook.com/market-research-reports/healthcare-market-research-report/neurodegenerative-diseases-market-to-2018-new-product-entries-in-both-niche-and-broader-parkinson%E2%80%99s-disease-treatment-will-boost-market-despite-patent-cliff.html Or visit us at: Bharat Book BureauPhone : +91 22 27810772, 27810773 Toll Free No for USA/Canada : 1-866-279-8368 Fax : +91 22 27812290 E-mail : info@bharatbook.com Website : www.bharatbook.comTwitter:https://twitter.com/BharatBookBlog:http://www.bharatbook.com/market-reports-blog/

More Related